Syndrome  >>  pioglitazone  >>  Phase 4
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
COMPLEMENT, NCT00672919: Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Completed
4
305
US
Pioglitazone, ACTOS®, AD-4833
Takeda
Diabetes Mellitus
08/04
08/04
NCT00494312: Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Completed
4
2120
US
Pioglitazone, Actos, AD-4833, Glyburide
Takeda
Diabetes Mellitus, Liver
06/05
06/05
NCT00754403: Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Completed
4
312
US
Pioglitazone and metformin, Actos, AD-4833XT, Fortamet, Metformin
Takeda
Diabetes Mellitus
10/06
10/06
NCT00314561: The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome

Completed
4
40
RoW
Pioglitazone, Rosiglitazone
Korea University Anam Hospital
Metabolic Syndrome
 
12/06
NCT00145340: Pioglitazone Treatment in Polycystic Ovary Syndrome

Completed
4
30
Europe
pioglitazone
Odense University Hospital
Polycystic Ovary Syndrome
01/07
01/07
NCT00203996: Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

Terminated
4
37
US
continuous positive airway pressure (CPAP), Continuous Positive Airway Pressure, depot leuprolide plus estrogen/progestin replacement, Lupron, pioglitazone, Actos, REM frag, SWS supp
University of Chicago, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Polycystic Ovary Syndrome, Obstructive Sleep Apnea
06/08
06/08
NCT00579813: Mechanisms Underlying Metabolic Syndrome in Obesity

Completed
4
70
US
Pioglitazone, Actos
Philip Kern, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Metabolic Syndrome, Insulin Resistance, Prediabetes
01/09
01/11
NCT00708175: Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

Completed
4
156
US
Pioglitazone, ACTOS®, Placebo
Takeda
Bone Metabolism
01/11
02/11
SPLENDOR, NCT00770835 / 2007-003077-44: Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Checkmark ADA 2013
Jun 2013 - Jun 2013: ADA 2013
Completed
4
39
Europe
Pioglitazone and Metformin, ACTOS®, AD-4833, Glibenclamide and Metformin, Diabeta, Glynase, Micronase, Daonil, Semi-Daonil, Euglucon
Takeda
Diabetes Mellitus
05/11
05/11
NCT00835120: Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Completed
4
34
US
Pioglitazone, Actos
University Hospitals Cleveland Medical Center, National Alliance for Research on Schizophrenia and Depression, Takeda Pharmaceuticals North America, Inc.
Metabolic Syndrome, Bipolar Depression, Insulin Resistance
04/13
04/13
NCT01612858: Metabolic Abnormalities in HIV-infected Persons

Completed
4
20
US
Metformin, Fortamet, Glucophage, Glumetza, Riomet, Pioglitazone, Actos
Tufts Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lipodystrophy, HIV Infection
11/14
11/14

Download Options